Sabby Management, LLC

Name: SABBY MANAGEMENT, LLC 13F holdings, Q1 2026
Creator: SABBY MANAGEMENT, LLC
Published: 2026-05-15

Q2 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Sabby Management, LLC reported 20 stock positions worth $5.3 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 33.6% of the portfolio, followed by Alpha Compute (ALP, 12.4%) and Senestech (SNES, 6.8%). Compared with Q4 2025, it opened 12 new positions, sold out of 16, added to 4 and reduced 4. The biggest buy was SS SPDR S&P 500 ETF Trust-US (SPY, shares +716%) and the biggest sale an exit from Big Tree Cloud Holdings LT-A (DSY).

Most Recent 13F: Q2 2026
Location: MIAMI BEACH, FL
CIK: 0001535610
Portfolio Value: $5.3M (Q1 2026)
SEC Filing: 0001104659-26-061764 ↗ filed May 15, 2026

Holdings Value

Holdings 20 stocks · $5.3M


SPY SS SPDR S&P 500 ETF Trust-US	33.61%	2,734	$1.8M	Add +716.1%
ALP Alpha Compute Corp. filed as ALPHATON CAPITAL CORP	12.38%	2,072,103	$655K	New
SNES Senestech Inc.	6.77%	218,533	$358K	Add +3.8%
DSY Big Tree Cloud Holdings LT-A	6.37%	137,611	$337K	New
BCTX Briacell Therapeutics Corp.	5.85%	73,915	$310K	New
TC Token Cat Ltd.	4.57%	23,239	$242K	New
CPOP Pop Culture Group Co. Ltd. Class A	3.80%	664,449	$201K	Reduce -30.5%
MBRX Moleculin Biotech Inc.	3.25%	75,021	$172K	New
BDRX Biodexa Pharmaceuticals PLC	3.01%	257,472	$159K	Add +35.0%
RKDA Arcadia Biosciences Inc.	2.99%	114,554	$158K	New
TRX TRX Gold Corp.	2.84%	100,000	$150K	New
INM Inmed Pharmaceuticals Inc.	2.69%	220,260	$142K	Add +9.2%
CANF Can Fite Biopharma Ltd.-ADR	2.49%	42,559	$132K	New
SXTC China SXT Pharmaceuticals-A	2.48%	78,170	$131K	New
REVB Revelation Biosciences Inc.	2.26%	99,432	$119K	New
CLDI Calidi Biotherapeutics Inc.	1.96%	434,903	$104K	New
BJDX Bluejay Diagnostics Inc.	1.00%	28,726	$53K	New
LYRA Lyra Therapeutics Inc.	0.97%	104,059	$51K	Reduce -40.6%
TPST Tempest Therapeutics Inc.	0.55%	17,856	$29K	Reduce -90.0%
BNBX BNB Plus Corp.	0.16%	13,541	$9K	Reduce -74.9%

Options reported separately and not counted above: STATE STR SPDR S&P 500 ETF T puts ($29.1M), ISHARES TR puts ($7.4M), GEVO INC puts ($1.4M), ABIVAX SA calls ($857K), ZEVRA THERAPEUTICS INC puts ($317K), SIDUS SPACE INC puts ($243K).

Other holdings (2): bonds, preferreds, convertibles and warrants · $421K (not counted above)

Security	Class	Shares / Principal	Value	Change
BCTXL Briacell Therapeutics Corp.	*W EXP 01/15/203	380,686	$392K	New
BCTXZ Briacell Therapeutics - 30	*W EXP 99/99/999	206,753	$29K	Reduce -22.3%

Total filed on the 13F, all lines: $5.7M.

Portfolio Sells Q4 2025 → Q1 2026


DSY Big Tree Cloud Holdings LT-A	Sold out	0.00%	−13.19
EMPD Empery Digital Inc.	Sold out	0.00%	−13.09
BLNK Blink Charging Co.	Sold out	0.00%	−11.89
BITCOIN DEPOT INC	Sold out	0.00%	−10.83
ABVX Abivax SA-ADR	Sold out	0.00%	−7.95
REVELATION BIOSCIENCES INC	Sold out	0.00%	−4.06
TPST Tempest Therapeutics Inc.	Reduce -90.0%	0.55%	−3.75
LYRA Lyra Therapeutics Inc.	Reduce -40.6%	0.97%	−3.56
ZONE Zone Frontier Inc.	Sold out	0.00%	−3.16
JZXN Jiuzi Holdings Inc.	Sold out	0.00%	−2.73
GVH Globavend Holdings Ltd.	Sold out	0.00%	−2.16
TIRXF Tian Ruixiang Holdings Ltd. Class A	Sold out	0.00%	−1.89
NOVA MINERALS LTD-ADR	Sold out	0.00%	−1.53
NUWE Nuwellis Inc.	Sold out	0.00%	−1.31
EEIQ Epicquest Education Group Inc.	Sold out	0.00%	−1.23
PMCB Pharmacyte Biotech Inc.	Sold out	0.00%	−0.61
OGEN Oragenics Inc.	Sold out	0.00%	−0.41
BNBX BNB Plus Corp.	Reduce -74.9%	0.16%	−0.39
LM FDG AMER INC	Sold out	0.00%	−0.10
CPOP Pop Culture Group Co. Ltd. Class A	Reduce -30.5%	3.80%	+0.43

Portfolio Buys Q4 2025 → Q1 2026


SPY SS SPDR S&P 500 ETF Trust-US	Add +716.1%	33.61%	+31.69
ALP Alpha Compute Corp.	New	12.38%	+12.38
DSY Big Tree Cloud Holdings LT-A	New	6.37%	+6.37
BCTX Briacell Therapeutics Corp.	New	5.85%	+5.85
TC Token Cat Ltd.	New	4.57%	+4.57
MBRX Moleculin Biotech Inc.	New	3.25%	+3.25
SNES Senestech Inc.	Add +3.8%	6.77%	+3.00
RKDA Arcadia Biosciences Inc.	New	2.99%	+2.99
TRX TRX Gold Corp.	New	2.84%	+2.84
CANF Can Fite Biopharma Ltd.-ADR	New	2.49%	+2.49
SXTC China SXT Pharmaceuticals-A	New	2.48%	+2.48
REVB Revelation Biosciences Inc.	New	2.26%	+2.26
CLDI Calidi Biotherapeutics Inc.	New	1.96%	+1.96
BJDX Bluejay Diagnostics Inc.	New	1.00%	+1.00
INM Inmed Pharmaceuticals Inc.	Add +9.2%	2.69%	+0.89
BDRX Biodexa Pharmaceuticals PLC	Add +35.0%	3.01%	−0.62

Options Activity Q4 2025 → Q1 2026


STATE STR SPDR S&P 500 ETF T	put	Add +28.1%	447	$29.1M
ISHARES TR	call	Sold out	564	$13.9Mbefore exit
ISHARES TR	put	Reduce -53.9%	300	$7.4M
GEVO INC	put	Reduce -16.3%	5,252	$1.4M
ABIVAX SA	call	Reduce -51.9%	77	$857K
ZEVRA THERAPEUTICS INC	put	Add +4.0%	340	$317K
SIDUS SPACE INC	put	New	1,049	$243K
REVIVA PHARMACEUTCLS HLDGS I	put	Sold out	4,113	$115Kbefore exit
EOS ENERGY ENTERPRISES INC	put	Sold out	3,251	$2Kbefore exit

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

Notes & Other Activity Q4 2025 → Q1 2026


BCTXL Briacell Therapeutics Corp.	*W EXP 01/15/203	New	380,686	$392K
BCTXZ Briacell Therapeutics - 30	*W EXP 99/99/999	Reduce -22.3%	206,753	$29K

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

Quarter	Positions	13F Reported Value	Top Holdings
Q2 2026	14	$11.8M	SPY, TOYO, FAMI, CRVO, TPST
Q1 2026	20	$5.3M	SPY, ALP, SNES, DSY, BCTX
Q4 2025	24	$11.9M	DSY, EMPD, BLNK, BITCOIN DEPOT INC, ABVX
Q3 2025	28	$19.1M	DSY, EMPD, CPOP, EVEX, CAN FITE BIOFARMA LTD
Q2 2025	32	$12.4M	TPST, EOSE, LYRA, LEXX, CAN FITE BIOFARMA LTD
Q1 2025	36	$23.8M	SRFM, IWM, LLY, EOSE, KSCP
Q4 2024	15	$12.3M	EOSE, SPY, IWM, VANI, BTBT
Q3 2024	24	$7.2M	VANI, VOLCON INC, HEALTHY CHOICE WELLNESS CORP, IMNN, CORZ
Q2 2024	22	$6.7M	VANI, RDHL, GREENWAVE TECHNOLOGY SOLUTIO, ELTK, IWM
Q1 2024	36	$13.9M	VANI, ELTK, RDHL, TNXP, GMM